3rd Circ. Revives Fosamax Warning Class Against Merck
The Third Circuit Wednesday revived a class action suit claiming Merck failed to warn patients about the risk of its osteoporosis drug Fosamax causing irregular hip fractures, saying the drugmaker must...To view the full article, register now.
Already a subscriber? Click here to view full article